MedTrace Logo

Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery

NCT03355534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-05-26

No results posted yet for this study

Summary

Dexmedetomidine induces analgesic and sedative effects and is reported to decrease agitation during emergence after general anesthesia in various surgeries. For patients undergoing cranial aneurysm surgeries, a calm anesthesia and emergence is important. In this study, the investigatorstend to observe the effect of dexmedetomidine on maintenance and recovery of patients undergoing cranial aneurysm surgeries.

Conditions

  • Aneurysm Cerebral

Interventions

DRUG

Intravenous dexmedetomidine

drug is intravenously infused to patients

DRUG

nasal dexmedetomidine

drug is nasally given to patients

DRUG

intravenous saline

saline is given to patients intravenously

DRUG

nasal saline

normal saline is given to patients nasally

Sponsors & Collaborators

  • Zhihong LU

    lead OTHER

Principal Investigators

  • Lize Xiong · Air Force Military Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-05
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03355534 on ClinicalTrials.gov